Philippe Généreux, MD Presents Novel Research on Aortic Stenosis from egnite, Inc.’s Database at Transcatheter Cardiovascular Therapeutics Conference 2023
Led by Philippe Généreux, MD and Colleagues, Findings Presented Today at the TCT Conference. Key Findings Demonstrate Patients With Aortic Stenosis Have Substantial Untreated Mortality Risk Across All Levels of Aortic Stenosis Severity, but Aortic Valve Replacement Rates Remain Low Even for Patients With Severe Aortic Stenosis…
egnite, Inc. and JenaValve Announce Strategic Partnership to Uncover Trends in Care for Patients with Aortic Regurgitation
Partnership aims to understand the care paradigm and associated outcomes for patients with aortic regurgitation. First study presented by Nick Amoroso, MD, at the TVT Structural Heart Summit in Phoenix, Arizona.
egnite, Inc. Announces Research from its Real-World Database at Heart Rhythm 2023
Study Led by John Mignone, M.D., Ph.D., Presented at the Heart Rhythm Society’s Annual Meeting. Key Findings Demonstrate Increased Survival for Patients Receiving Combined Device and 4-Class Medical Therapy.
Ancora Heart Inc. and egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients
Use of artificial intelligence technology efficiently identifies eligible patient candidates for pivotal clinical trial; program launched at The Christ Health Network.
egnite Announces Portfolio Expansion to Reduce Stroke Risk in Atrial Fibrillation Patients
Expansion leverages a custom module to help health systems identify patients eligible for lifesaving therapy.